Researchers



Results 41-60 of 92
Issue DateTitleAuthor(s)TypeМp-cat.
2021Epigenetic drug discovery: Successful examples of Computer-Aided Drug Designing of Histone Deacetylase (HDAC6 and SIRT2) and Histone Methyltransferase (DOT1L) inhibitorsRuzic, Dušan  ; Đoković, Nemanja B.  ; Bon C.; Petkovic, M.  ; Ellinger B.; Gul, S.; Santibanez F. J.; Lahtela-Kakkonen, M.; Halby L.; Ganesan, A.;
Srdic-Rajic T.  ; Arimondo P.; Nikolić, Katarina M.  ;
Conference Paper
Mp. category will be shown later
2021Fragment-Based Drug Design of Selective HDAC6 InhibitorsRužić, PhD, Dušan  Book parts
Mp. category will be shown later
2021An Integrative in silico Drug Repurposing Approach for Identification of Potential Inhibitors of SARS-CoV-2 Main ProteaseĐoković, Nemanja  ; Ružić, Dušan  ; Đikić, Teodora ; Cvijić, Sandra  ; Ignjatović, Jelisaveta ; Ibrić, Svetlana  ; Baralić, Katarina  ; Buha-Đorđević, Aleksandra  ; Ćurčić, Marijana  ; Đukić-Ćosić, Danijela  ;
Nikolić, Katarina  ;
Article
21M21
2021Medicinal chemistry of histone deacetylase inhibitorsRužić, Dušan  ; Đoković, Nemanja  ; Nikolić, Katarina  ; Vujić, Zorica  Article
52M52
2021RATIONAL DESIGN, SYNTHESIS AND IN VITRO TESTING OF - SELECTIVE HDAC6 AND SIRT2 INHIBITORSDusan Ruzic  ; Đoković, Nemanja B.  ; Milos Petkovic  ; Danica Agbaba ; Sheraz Gul; Maija Lahtela-Kakkonen; A. Ganesan; Juan F. Santibanez; Tatjana Srdic-Rajic  ; Nikolić, Katarina M.  Conference Paper
Mp. category will be shown later
2021Application of Computational Methods for Antipsychotic Drug Design and OptimizationRadan, Milica  ; Ružić, Dušan  ; Antonijević, Mirjana; Đikić, Teodora ; Nikolić, Katarina  Conference Paper
Mp. category will be shown later
2021Novel 1-benzhydryl piperazine derivative inhibits the migration and invasiveness of breast cancer cells: Synthesis, molecular modelling and biological characterizationRužić, Dušan  ; Petković, Miloš  ; Gul, Sheraz; Santibanez, Juan  ; Srdić-Rajić, Tatjana  ; Nikolić, Katarina  Conference Paper
Mp. category will be shown later
2021Synthesis, molecular modelling and biological characterization of novel antimigratory and antiinvasive 1-benzhydryl piperazine derivativesDusan Ruzic  ; Milos Petkovic  ; E. Bernhard; Sheraz Gul; J.F. Santibanez; Tatjana Srdic Rajic  ; Nikolić, Katarina M.  Conference Paper
Mp. category will be shown later
2020In silico rational drug design and modelling studies of novel 5-HT2A receptor antagonistsRadan, Milica M.  ; Ružić, Dušan B.  ; Mirjana Antonijevic; Teodora Djikic; Nikolić, Katarina M.  Conference Paper
Mp. category will be shown later
2020In silico Identification of Novel 5-HT2A Antagonists Supported with Ligand- and Target- Based Drug Design MethodologiesRadan, Milica  ; Ružić, Dušan  ; Antonijevic, Mirjana; Djikic, Teodora; Nikolić, Katarina  Article
21M21
2020Discovery of new 5-HT2A receptor antagonists with a strategy of combining ligand and target-based drug design methodologiesRadan, Milica M.  ; Ružić, Dušan B.  ; Mirjana Antonijevic; Teodora Djikic; Nikolić, Katarina M.  Conference Paper
Mp. category will be shown later
2020COST Action 17104 (STRATAGEM), WG2 Meeting and International Online Symposium on: Multitargeting epi-epi drugs for multidrug resistanceAdam Lee; A. Ganesan; I. Bulut; Ceyda Açılan Ayhan; Ružić, Dušan B.  ; Nikolić, Katarina M.  ; Sheraz GulConference Paper
Mp. category will be shown later
2020In silico rational druga design and modelling studies of novel 5-HT2A receptor antagonstsRadan, Milica  ; Ružić, Dušan  ; Antonijević, Mirjana; Đikić, Teodora ; Nikolić, Katarina  Conference Paper
Mp. category will be shown later
2020In silico Methods for Design of Kinase Inhibitors as Anticancer DrugsGagić, Žarko ; Ružić, Dušan  ; Đoković, Nemanja  ; Đikić, Teodora ; Nikolić, Katarina  Article
21M21
2020Combined ligand-based and structure-based approaches in rational drug design of novel 5-HT2A receptor antagonistsRadan, Milica M.  ; Ružić, Dušan B.  ; Mirjana Antonijevic; Teodora Djikic; Nikolić, Katarina M.  Conference Paper
Mp. category will be shown later
2020Multitargeting epi-epi drugs for multidrug reistanceLee, Adam; Ganesan, A.; Bulut, İpek; Açılan Ayhan, Ceyda; Ružić, Dušan  ; Nikolić, Katarina  ; Gul, SherazConference Paper
Mp. category will be shown later
2019Is there a borderline between cytotoxic and antimetastatic effects of selective Histone deacetylase 6 inhibitors in solid malignancies?Nikolić, Katarina M.  ; Ružić, Dušan B.  ; Milan Beljkas  ; Petković, Miloš R.  ; Sheraz Gul; Juan F. Santibanez; Srdić-Rajić, Tatjana V.  Conference Paper
Mp. category will be shown later
2019Structure and ligand based drug design strategies in the development of novel serotonin 5-HT2A receptor antagonistsRadan, Milica M.  ; Mirjana Antonijevic; Ružić, Dušan B.  ; Đikić, Teodora M. ; Danica Agbaba; Nikolić, Katarina M.  Conference Paper
Mp. category will be shown later
2019Combined Ligand and Fragment-based Drug Design of Selective Histone Deacetylase-6 InhibitorsRužić, Dušan  ; Petković, Miloš  ; Agbaba, Danica ; Ganesan, A.; Nikolić, Katarina  Article
21M21
2019Development and Screening of Novel Chemical Probes Targeting Histone MethyltransferaseSi, Yang; Bon, Corentin; Ružić, Dušan  ; Nikolić, Katarina  ; Agou, Fabrice; Halby, Ludovic; Arimondo, PaolaConference Paper
Mp. category will be shown later